- Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Apellis enters drug development and commercialisation deal with Sobi

Apellis will receive an upfront payment of $250m from Sobi. Credit: © Swedish Orphan Biovitrum AB.